Codexis (CDXS) Total Non-Current Liabilities (2010 - 2026)

Codexis' (CDXS) quarterly Total Non-Current Liabilities came in at $84.8 million in Q1 2026, up 8.75% year-on-year from $78.0 million in Q1 2025, and down 11.61% quarter-over-quarter from $95.9 million in Q4 2025.

Codexis (CDXS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Codexis' Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $84.8 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 8.75% year-over-year to $84.8 million in Q1 2026; TTM through Mar 2026 was $84.8 million, a 8.75% increase from a year earlier, with the FY2025 full-year figure at $95.9 million, up 18.72% from the prior year.
  • Total Non-Current Liabilities slipped to $84.8 million in Q1 2026 per CDXS's latest filing, from $95.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $104.2 million in Q4 2022 and bottomed at $48.7 million in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $79.8 million (2022), against an average of $78.4 million.
  • Across the five-year window, Total Non-Current Liabilities plunged 53.26% in 2023 and soared 65.9% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $104.2 million in 2022, then plunged by 53.26% to $48.7 million in 2023, then surged by 65.9% to $80.8 million in 2024, then rose by 18.72% to $95.9 million in 2025, then retreated by 11.61% to $84.8 million in 2026.
  • Per Business Quant, the three latest CDXS Total Non-Current Liabilities figures stand at $84.8 million (Q1 2026), $95.9 million (Q4 2025), and $84.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn 84.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.80 Mn
Dec 31, 2025 95.94 Mn
Sep 30, 2025 84.11 Mn
Jun 30, 2025 81.32 Mn
Mar 31, 2025 77.98 Mn
Dec 31, 2024 80.82 Mn
Sep 30, 2024 73.50 Mn
Jun 30, 2024 69.30 Mn
Mar 31, 2024 69.04 Mn
Dec 31, 2023 48.71 Mn
Sep 30, 2023 61.73 Mn
Jun 30, 2023 81.23 Mn
Mar 31, 2023 90.66 Mn
Dec 31, 2022 104.23 Mn
Sep 30, 2022 79.80 Mn
Jun 30, 2022 74.17 Mn
Mar 31, 2022 75.31 Mn
Dec 31, 2021 80.68 Mn
Sep 30, 2021 57.45 Mn
Jun 30, 2021 48.25 Mn